Vitro CPK (MB) reagent is an immunoinhibition assay intended for the in vitro quantitative determination of Creatine Kinase (CK-MB) in human serum and plasma.
Exhibitions
Meet this supplier at the following exhibition(s):
MEDICA 2024
11-14 Nov 2024Dusseldorf (Germany)Hall 3 - Stand C15
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.